Dark

Check out our Level2View

EPIX
ESSA Pharma Inc. Common Stock
stock NASDAQ

Inactive

Oct 8, 2025

0.2012USD-1.854%(-0.0038)5,945,141

Pre-market

0.00USD-100.000%(-0.21)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 19, 2022

07:07AM EST ESSA Pharma Announces First Patient Dosed In Phase 1/2 Clinical Trial Of EPI-7386 In Combination With Enzalutamide In Patients With Metastatic Castration-Resistant Prostate Cancer Benzinga

07:01AM EST EPI-7386 in Combination with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer PR Newswire

Nov 22, 2021

02:41PM EST EPIX: Combination Studies Set to Initiate Benzinga

02:16PM EST Watching ESSA Pharma Shares; Zacks Small-Cap Research Sets $40 Valuation Benzinga

Nov 18, 2021

07:26AM EST ESSA Pharma Q4 EPS $(0.20) Down From $(0.17) YoY Benzinga

07:02AM EST ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal PR Newswire

Nov 8, 2021

07:02AM EST ESSA Pharma to Participate in Three Upcoming Investor Conferences PR Newswire

Oct 28, 2021

04:06PM EDT ESSA Pharma Presents at 28th Annual Prostate Cancer Foundation Scientific PR Newswire

Oct 7, 2021

10:48AM EDT ESSA Pharma, Caris Life Sciences Ink Liquid Biopsy Profiling Pact Benzinga

09:21AM EDT ESSA Pharma Announces Presentation Of Preclinical Data Characterizing Mechanism Of Action Of EPI-7386 RTTNews

09:05AM EDT ESSA Pharma Announces the Presentation of Preclinical Data Characterizing the PR Newswire

06:38AM EDT Caris Life Sciences And ESSA Pharma Announce Liquid Biopsy Profiling Collaboration Benzinga

06:30AM EDT Caris Life Sciences and ESSA Pharma Announce Liquid Biopsy Profiling PR Newswire

Aug 31, 2021

04:06PM EDT ESSA Pharma to Present at Upcoming September Investor Conferences PR Newswire

Aug 29, 2021

04:41AM EDT EPIX: Unwarranted Selloff Following Phase 1 Trial Update Benzinga

Aug 17, 2021

07:21AM EDT Oppenheimer Maintains Outperform on ESSA Pharma, Lowers Price Target to $22 Benzinga

Aug 16, 2021

02:32PM EDT Mid-Afternoon Market Update: Dow Turns Positive; Sesen Bio Shares Plummet Benzinga

12:13PM EDT Mid-Day Market Update: Crude Oil Down Over 2%; Travere Therapeutics Shares Jump Benzinga

10:22AM EDT Mid-Morning Market Update: Markets Open Lower; Empire State Manufacturing Index Dips In August Benzinga

07:28AM EDT ESSA Pharma Q3 EPS $(0.21) Up From $(0.24) YoY Benzinga

07:05AM EDT ESSA Pharma Q3 Net Loss $8.8 Mln Vs. Net Loss $4.9 Mln Last Year RTTNews

07:01AM EDT ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal PR Newswire

May 26, 2021

07:33AM EDT The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing Benzinga

May 25, 2021

07:53AM EDT The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal Benzinga

07:02AM EDT ESSA Pharma to Present at the Jefferies Virtual Healthcare Conference PR Newswire

May 21, 2021

07:26AM EDT The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying Benzinga

May 20, 2021

08:27AM EDT The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Order Flow Abounds, Voyager CEO, CMO To Depart, Decision Day For Bristol-Myers Squibb, ASCO Abstracts Move Stocks Benzinga

May 10, 2021

03:01PM EDT EPIX: Combination Trials Upcoming with Astellas, Bayer, and Benzinga

May 6, 2021

08:21AM EDT ESSA Pharma Q2 EPS $(0.36) Up From $(0.45) YoY Benzinga

07:02AM EDT ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal PR Newswire

Apr 28, 2021

07:19AM EDT ESSA Collaborates With Bayer To Evaluate Combination Of EPI-7386 And Darolutamide In MCRPC Cancer RTTNews

07:14AM EDT ESSA Pharma Announces Clinical Collaboration Agreement with Bayer to Evaluate the Combination of EPI-7386 and Darolutamide in Patients with Metastatic Castration-Resistant Prostate Cancer Benzinga

07:02AM EDT the Combination of EPI-7386 and Darolutamide in Patients with Metastatic Castration-Resistant Prostate Cancer PR Newswire

Apr 17, 2021

11:11AM EDT EPIX: Additional Preclinical Data Shows EPI-7386 Inhibits AR-Driven Transcription Benzinga

Apr 14, 2021

07:01AM EDT ESSA Pharma to Present at the Bloom Burton & Co. Healthcare Investor Conference PR Newswire

Apr 12, 2021

10:14AM EDT ESSA Pharma Saturday Morning Announced Presentation Of Preclinical Data On Co.'s EPI-7386 At American Association Of Cancer Research Meeting Apr. 10 Benzinga

Apr 10, 2021

08:31AM EDT EPI-7386 at the 2021 American Association of Cancer Research (AACR) Annual Meeting PR Newswire

Mar 26, 2021

04:05PM EDT ESSA Announces Change to its Board of Directors PR Newswire

Mar 4, 2021

11:33AM EST ESSA Pharma Announces Exercise of Option in Connection with Recently Completed PR Newswire

10:10AM EST Benzinga's Top Ratings Upgrades, Downgrades For March 4, 2021 Benzinga

05:52AM EST Piper Sandler Initiates Coverage On ESSA Pharma with Overweight Rating, Announces Price Target of $50 Benzinga

Feb 25, 2021

06:34PM EST ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of PR Newswire

04:31PM EST ESSA Pharma to Present at Upcoming March Investor Conferences PR Newswire

09:16AM EST HC Wainwright & Co. Maintains Buy on ESSA Pharma, Lowers Price Target to $32 Benzinga

07:30AM EST ESSA Pharma Reports Collaboration With Astellas To Evaluate Combo Of EPI-7386, Enzalutamide For Patients With Metastatic Castration-Resistant Prostate Cancer Benzinga

07:03AM EST Combination of EPI-7386 and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer PR Newswire

Feb 22, 2021

11:50AM EST ESSA Pharma Reports Closing OF 4.83M Share Offering At $27/Share Benzinga

11:49AM EST ESSA Pharma Announces Closing of $130 Million Public Offering of Common Stock PR Newswire

Feb 17, 2021

10:58PM EST ESSA Pharma Announces Pricing Of Public Offering Of 4.83 Mln Common Shares At $27/Shr RTTNews

10:48PM EST ESSA Pharma Announces Pricing of Public Offering of Common Shares PR Newswire

07:27AM EST The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal Benzinga

Feb 16, 2021

04:01PM EST ESSA Pharma Announces $100M Proposed Common Stock Offering Benzinga

04:01PM EST ESSA Pharma Announces Proposed Public Offering of Common Shares PR Newswire

Feb 11, 2021

11:21AM EST HC Wainwright & Co. Maintains Buy on ESSA Pharma, Raises Price Target to $36 Benzinga

11:21AM EST Stocks That Hit 52-Week Highs On Thursday Benzinga

11:21AM EST ESSA Pharma's Interim EPI-7386 Data Shows Continuous Antigen Decline In Early-Stage Prostate Cancer Study Benzinga

08:12AM EST ESSA Pharma Presents Favorable Initial Phase 1 Pharmacology Data Of EPI-7386 For Advanced Forms Of Prostate Cancer RTTNews

08:03AM EST EPI-7386 for Advanced Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium PR Newswire

07:58AM EST ESSA Pharma Q1 Net Loss $6.5 Mln Or $0.20/shr Vs Loss Of $4.6 Mln Or $0.22/shr Prior Year RTTNews

07:01AM EST ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal PR Newswire

Jan 27, 2021

07:36AM EST The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement Benzinga

Jan 22, 2021

07:22AM EST The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa Benzinga

Jan 21, 2021

08:05AM EST The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping Benzinga

Jan 20, 2021

07:32AM EST The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study Benzinga

Jan 15, 2021

07:57AM EST The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges Benzinga

Jan 14, 2021

07:57AM EST The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates Benzinga

Jan 13, 2021

07:23AM EST ESSA Pharma Enters Clinical Collaboration And Supply Agreement With Janssen Research & Development, LLC RTTNews

07:19AM EST ESSA, Janssen To Evaluate EPI-7386 Combination For Patients With Metastatic Castration-Resistant Prostate Cancer RTTNews

07:10AM EST ESSA Pharma Announces Clinical Collaboration With Janssen To Evaluate EPI-7386 Combination For Patients With Metastatic Castration-Resistant Prostate Cancer Benzinga

07:02AM EST ESSA Pharma Enters Clinical Collaboration With Janssen To Evaluate EPI-7386 Combination For Patients With MCRPC RTTNews

07:01AM EST ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 PR Newswire

Jan 12, 2021

08:16AM EST The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue Benzinga

07:07AM EST Pfizer Inc. (PFE) announced Tuesday that it invested a total of $120 million in four clinical-stage biotech companies during the second half of 2020 as part of the Pfizer Breakthrough Growth Initiative (PBGI). RTTNews

06:50AM EST Pfizer Invests $120 Million in Biotechnology Innovation Through the Pfizer Breakthrough Growth Initiative Benzinga

Jan 11, 2021

06:34AM EST HC Wainwright & Co. Maintains Buy on ESSA Pharma, Raises Price Target to $17 Benzinga

Jan 8, 2021

07:25AM EST The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs Benzinga

Jan 1, 2021

01:43AM EST EPIX: Clinical Data for EPI-7386 in 2021 Benzinga

Dec 29, 2020

08:09AM EST The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica Benzinga

Dec 23, 2020

08:31AM EST The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut Benzinga

Dec 15, 2020

05:02PM EST ESSA Pharma Q4 EPS $(0.17) Down From $(0.07) YoY Benzinga

05:01PM EST ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal PR Newswire

Nov 25, 2020

07:01AM EST ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference PR Newswire

Nov 10, 2020

07:01AM EST ESSA Pharma to Participate in Upcoming Investor Conferences PR Newswire

Oct 26, 2020

05:01PM EDT ESSA Pharma Inc. Announces Delisting from the TSX-V PR Newswire

Oct 24, 2020

07:19PM EDT ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR PR Newswire

Oct 19, 2020

07:01AM EDT ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming PR Newswire

Sep 21, 2020

07:01AM EDT ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & PR Newswire

Sep 17, 2020

05:06PM EDT ESSA Pharma Announces The Presentation Of Additional Preclinical Data For EPI-7386 At The ESMO Virtual Congress Benzinga

05:06PM EDT ESSA Pharma Announces the Presentation of Additional Preclinical Data for PR Newswire

Sep 14, 2020

07:16AM EDT ESSA Pharma: FDA Grants Fast Track Designation To EPI-7386 For Metastatic Castration-Resistant Prostate Cancer RTTNews

07:10AM EDT ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resistant Prostate Cancer Benzinga

07:01AM EDT ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for PR Newswire

Aug 6, 2020

08:53PM EDT ESSA Pharma Q3 Net Loss Of $4.9 Mln Or $0.24/shr Vs. Net Loss Of $3.3 Mln Or $0.52/shr Prior Year RTTNews

08:00PM EDT ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal PR Newswire

Jul 31, 2020

10:18AM EDT ESSA Pharma Completes Public Offering For Aggregate Gross Proceeds Of US$48.99 Mln RTTNews

10:17AM EDT ESSA Pharma Completes Public Offering for Aggregate Gross Proceeds of PR Newswire

Jul 29, 2020

07:11AM EDT ESSA Pharma Shares Now Open For Trade Benzinga

05:25AM EDT ESSA Pharma Prices 7.1 Share Public Offering @$6/Share Benzinga

Jul 28, 2020

09:51PM EDT ESSA Pharma Announces Pricing Of Underwritten Public Offering Of 7.10 Mln Shares At US$6.00/shr RTTNews

09:19PM EDT ESSA Pharma Announces Pricing of Public Offering of Common Shares PR Newswire

04:05PM EDT ESSA Pharma Proposes A Common Stock Offering; No Size Disclosed Benzinga

04:02PM EDT ESSA Pharma Announces Proposed Public Offering of Common Shares PR Newswire

Jul 15, 2020

07:09AM EDT ESSA Pharma Announces First Patient Dosed In A Phase 1 Clinical Trial Of EPI-7386 For MCRPC RTTNews

07:05AM EDT ESSA Pharma Announces First Patient Dosed In A Phase 1 Clinical Trial Of EPI-7386 For Metastatic Castration-Resistant Prostrate Cancer Benzinga

07:01AM EDT ESSA Pharma Announces First Patient Dosed in a Phase 1 Clinical Trial of PR Newswire

Share